BioNTech SE

Did you see the video footage over the weekend of those trucks leaving the Pfizer Inc. (NYSE: PFE) manufacturing plant in Michigan—the ones filled with the first shipments of the coronavirus vaccine it developed with BioNTech SE (NASDAQ: BNTX)? It seems many investors did...

What’s old is new again. Remember Brexit? Well, the market is reacting again to news about Britain’s divorce from the European Union, with the U.S. market following European shares lower on the possibility of the United Kingdom leaving the bloc this month without a trade agreement in...

If this morning is any indication, trading today could be a bit of a waiting game. As investors arrive at their desks—at home or in the office—it seems they’re looking for clarity on two big events that would likely move the market and affect the economy. One of those things is...

The big economic news this morning is the government’s latest jobs report, which came in below expectations. But before that came out, investors and traders seemed optimistic, as stimulus talks seem to be picking up steam in Washington.  That hope, enhanced by optimism about a vaccine,...

Investors this morning seem to be continuing to weigh competing forces.  On the one hand, surging coronavirus cases and related state restrictions to curb the virus’s spread seem to be weighing on sentiment, exacerbated by news that California has banned nonessential work and gatherings...

Earlier this week, meaningful progress on the pandemic front was announced after Pfizer Inc. (NYSE: PFE) and partner BioNTech SE (NASDAQ: BNTX) said their Covid-19 vaccine was highly effective in combating the virus. This compelling news rewarded value investors that held to their beliefs, stuck...

(Tuesday Market Open) As earnings season shifts into a higher gear during this busy week, investors not only have quarterly corporate performance on their mind but also the congressional debate about another round of stimulus and a Fed meeting where market participants are likely hoping to hear...